Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash Flows from Operating Activities
Net income	$ 23,601	$ 17,914
Adjustment to reconcile net income to net cash provided by operating activities:
Depreciation	430	647
Right of use asset amortization	1,033	1,068
Provision for loan losses		2,780
Share-based compensation expense	402	396
Net amortization of securities	68	338
Fair value adjustment on equity securities	498	(85)
Amortization of debt issuance costs	296	37
Net (gains) losses on premises and equipment	1	(19)
Gains on sales and calls of available-for-sale securities		(10)
Deferred tax expense (benefit)	670	(664)
Net increase in cash surrender value of life insurance	(73)	(309)
Changes in assets and liabilities:
Decrease in accrued interest receivable	199	647
Increase in other assets	(732)	(106)
Decrease in accrued interest payable	(200)	(266)
Increase (decrease) in other liabilities	(1,030)	283
Net cash provided by operating activities	25,163	22,651
Cash Flows from Investing Activities
Net increase in loans	(58,645)	(39,944)
Purchase of available-for-sale securities	(206,889)	(217,460)
Purchase of held-to-maturity securities	(1,003)	(6,031)
Proceeds from maturities, calls and principal repayments of available-for-sale securities	41,151	28,428
Proceeds from maturities, calls and principal repayments of held-to-maturity securities	5,712	1,492
Net redemption of restricted securities	530	728
Net purchase of equity securities	(542)	(628)
Insurance casualty proceeds		22
Purchases of bank premises and equipment	(142)	(286)
Net cash (used in) investing activities	(219,828)	(233,679)
Cash Flows from Financing Activities
Net increase in deposits	181,788	197,428
Net repayment of Federal Home Loan Bank advances	(18,000)	(4,000)
Issuance of subordinated debt	24,579
Repayment of subordinated debt	(25,000)
Cash dividends paid	(2,799)
Issuance of common stock for share options exercised	3,054	217
Net cash provided by financing activities	163,622	193,645
Net decrease in cash and cash equivalents	(31,043)	(17,383)
Cash and cash equivalents, beginning of period	105,799	121,074
Cash and cash equivalents, end of period	74,756	103,691
Supplemental Disclosures of Cash Flow Information
Interest	7,497	6,705
Income taxes	4,387	5,141
Supplemental Disclosures of Noncash Transactions
Unrealized loss on securities available-for-sale	(38,480)	(3,575)
Right of use asset obtained in exchange for new operating lease liability	$ 56	$ 385